Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACDC Study: Early laparoscopic cholecystectomy vs antibiotic therapy with delayed elective cholecystectomy in acute cholecystitis
2006-002056-14Phase 3Completed
- Sponsor
- Heidelberg University Hospital
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of moxifloxacin in acute cholecystitis (2 arms), sponsored by Heidelberg University Hospital. Primary endpoint: Primary morbidity over 75 days after enrollment. Started Jun 2006; status: completed.
02
Drugs
moxifloxacin
03
Conditions
acute cholecystitis
Beyond the preview
Go deeper on 2006-002056-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002056-14.